🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 15 horas
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 06/03/2012 | 36,24 | 36,62 | 35,59 | 35,73 | -2,63% | 2,84% | 19.487.874 |
| 05/03/2012 | 36,27 | 36,76 | 36,25 | 36,69 | +1,37% | 1,39% | 19.558.929 |
| 02/03/2012 | 35,90 | 36,35 | 35,84 | 36,19 | +0,37% | 1,41% | 13.676.819 |
| 01/03/2012 | 36,40 | 36,41 | 35,94 | 36,06 | -1,00% | 1,31% | 18.920.068 |
| 29/02/2012 | 36,71 | 36,73 | 36,37 | 36,42 | -0,55% | 0,96% | 15.971.520 |
| 28/02/2012 | 36,40 | 36,73 | 36,26 | 36,62 | +0,60% | 1,28% | 9.916.071 |
| 27/02/2012 | 36,20 | 36,51 | 36,10 | 36,40 | -0,13% | 1,13% | 17.304.052 |
| 24/02/2012 | 36,73 | 36,74 | 36,39 | 36,45 | -0,80% | 0,94% | 8.896.996 |
| 23/02/2012 | 36,36 | 36,76 | 36,36 | 36,75 | +0,76% | 1,10% | 10.823.954 |
| 22/02/2012 | 36,32 | 36,48 | 36,16 | 36,47 | +0,24% | 0,87% | 10.304.984 |
| 21/02/2012 | 36,71 | 36,86 | 36,34 | 36,38 | -1,12% | 1,43% | 11.373.106 |
| 17/02/2012 | 36,85 | 37,10 | 36,56 | 36,79 | +1,10% | 1,45% | 18.826.586 |
| 16/02/2012 | 36,34 | 36,40 | 36,07 | 36,39 | +0,32% | 0,92% | 10.933.574 |
| 15/02/2012 | 36,51 | 36,53 | 36,15 | 36,28 | -0,50% | 1,02% | 12.769.670 |
| 14/02/2012 | 36,36 | 36,49 | 36,21 | 36,46 | +0,26% | 0,76% | 11.704.378 |
| 13/02/2012 | 36,36 | 36,49 | 36,24 | 36,36 | +0,53% | 0,68% | 12.179.437 |
| 10/02/2012 | 36,20 | 36,27 | 36,05 | 36,17 | -0,63% | 0,61% | 11.026.113 |
| 09/02/2012 | 36,63 | 36,76 | 36,39 | 36,40 | -0,70% | 0,99% | 10.058.390 |
| 08/02/2012 | 36,78 | 36,83 | 36,47 | 36,66 | -0,54% | 0,99% | 11.877.194 |
| 07/02/2012 | 36,52 | 37,00 | 36,50 | 36,86 | +0,60% | 1,38% | 13.044.875 |
| 06/02/2012 | 36,46 | 36,64 | 36,38 | 36,64 | +0,08% | 0,71% | 11.561.850 |
| 03/02/2012 | 36,74 | 36,82 | 36,34 | 36,61 | -0,18% | 1,32% | 15.730.690 |
| 02/02/2012 | 37,16 | 37,19 | 36,26 | 36,68 | -0,49% | 2,49% | 21.778.174 |
| 01/02/2012 | 36,78 | 37,22 | 36,56 | 36,86 | +0,94% | 1,79% | 15.276.801 |
| 31/01/2012 | 37,19 | 37,20 | 36,44 | 36,52 | -1,59% | 2,05% | 17.268.525 |
| 30/01/2012 | 36,62 | 37,12 | 36,52 | 37,11 | +0,96% | 1,64% | 13.324.586 |
| 27/01/2012 | 36,96 | 37,02 | 36,47 | 36,76 | -0,67% | 1,50% | 12.702.389 |
| 26/01/2012 | 37,06 | 37,17 | 36,77 | 37,00 | +0,26% | 1,06% | 12.983.462 |
| 25/01/2012 | 36,80 | 37,01 | 36,51 | 36,91 | -0,26% | 1,37% | 15.170.010 |
| 24/01/2012 | 37,19 | 37,41 | 36,88 | 37,00 | +0,03% | 1,44% | 13.775.646 |